Signalling, trafficking and glucoregulatory properties of glucagon‐like peptide‐1 receptor agonists exendin‐4 and lixisenatide-Reference-Cited by-同舟云学术

Signalling, trafficking and glucoregulatory properties of glucagon‐like peptide‐1 receptor agonists exendin‐4 and lixisenatide

Published:2020-06-19 Issue:17 Volume:177 Page:3905-3923
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Pickford Philip¹,Lucey Maria¹,Fang Zijian¹,Bitsi Stavroula²,Serna Jorge Bernardino³^ORCID,Broichhagen Johannes⁴⁵,Hodson David J.⁶⁷,Minnion James¹,Rutter Guy A.²,Bloom Stephen R.¹,Tomas Alejandra²,Jones Ben¹

Affiliation:

1. Section of Endocrinology and Investigative Medicine Imperial College London London UK

2. Section of Cell Biology and Functional Genomics Imperial College London London UK

3. National Heart and Lung Institute Imperial College London London UK

4. Department Chemical Biology Max Planck Institute for Medical Research Heidelberg Germany

5. Department Chemical Biology Leibniz‐Forschungsinstitut für Molekulare Pharmakologie (FMP) Berlin Germany

6. Institute of Metabolism and Systems Research (IMSR), and Centre of Membrane Proteins and Receptors (COMPARE) University of Birmingham Birmingham UK

7. Centre for Endocrinology, Diabetes and Metabolism Birmingham Health Partners Birmingham UK

Funder

Academy of Medical Sciences

Diabetes UK

Horizon 2020 Framework Programme

European Research Council

Engineering and Physical Sciences Research Council

National Institute for Health Research

Biotechnology and Biological Sciences Research Council

Medical Research Council

Publisher

Wiley